Catalyst Wire Dossier Catalyst Wire Dossier

Measles Vaccine MVA mBN85B

· Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Measles Vaccine MVA mBN85B, covering 2012-07-27 to 2012-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years [Phase 2]

See pricing